fda warning letter hims compounded semaglutide september 2025 From Crackdown to Collaboration: Letters and the Hims-Novo Nordisk Deal Signal a New Era for GLP-1 Drugs FDA Sends Warning Letters to
Description
Comparative efficacy on weight loss When examining the comparative efficacy of weight loss between semaglutide and Zepbound, clinical studies provide a wealth of data demonstrating their effectiveness

Based on how GLP-1 class drugs work, the drug reduces appetite and increases satiety, which naturally reduces caloric intake
Some patients may have diagnoses for both and would be counted as having diabetes
George Conway, the former conservative lawyer-turned-Trump critic, filed paperwork to run for Congress in New York City as a Democrat

If it appears thickened, grainy, or syrupy, degradation has occurred